Diffuse large B cell lymphoma screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(One intermediate revision by one other user not shown) | |||
Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{AS}} | {{CMG}}; {{AE}} {{AS}} | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for diffuse large B cell lymphoma. | |||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for diffuse large B cell lymphoma. | |||
==References== | ==References== | ||
Line 16: | Line 17: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] |
Latest revision as of 18:08, 22 January 2019
Diffuse large B cell lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Diffuse large B cell lymphoma screening On the Web |
American Roentgen Ray Society Images of Diffuse large B cell lymphoma screening |
Directions to Hospitals Treating Diffuse large B cell lymphoma |
Risk calculators and risk factors for Diffuse large B cell lymphoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
There is insufficient evidence to recommend routine screening for diffuse large B cell lymphoma.
Screening
There is insufficient evidence to recommend routine screening for diffuse large B cell lymphoma.